Business
Exagen Inc. Reports Record Q1 2025 Revenue Driven by Growth in Average Selling Price and Testing Volume
CARLSBAD, Calif., May 05, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended March 31, 2025, and recent corporate updates. Three Months Ended March 31, 2025 2024 (in thousands, except ASP data) Revenue $15,498 $14,415 Gross margin 58.9% 59.6%Operating expenses $12,488 $11,601 Operating loss $(3,365) $(3,003)Net loss $(3,752) $(3,360)Adjusted EBITDA $(2,508) $(1,992)Cash and cash equivalent
About this update from Exagen Inc.
[{"type":"image","alt":"Exagen Inc.","displaySize":"","headline":null,"caption":"Exagen Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":84,"url":"https://media.zenfs.com/en/globenewswire.com/14dcf296c8db7fb07c938fd3210e3716"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/s5kZKXkkz0E4OBFbX6qSYA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTExODtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/14dcf296c8db7fb07c938fd3210e3716","width":300,"height":84}},"lazy":false},{"type":"text","content":"CARLSBAD, Calif., May 05, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended March 31, 2025, and recent corporate updates.","length":235,"tagName":"p"},{"type":"table","headerItems":[],"items":[{"val":[{"style":"vertical-align:bottom;","val":[{"type":"text","content":" ","length":6,"tagName":"p","attribs":{}}]},{"style":"vertical-align:bottom;","val":[{"type":"text","content":" ","length":6,"tagName":"p","attribs":{}}]},{"colspan":"7","style":"text-align:center;vertical-align:middle;vertical-align:bottom;","val":[{"type":"text","content":"Three Months Ended March 31,","length":28,"tagName":"p","attribs":{}}]}]},{"val":[{"style":"max-width:70%;width:70%;min-width:70%;vertical-align:bottom;","val":[{"type":"text","content":" ","length":6,"tagName":"p","attribs":{}}]},{"style":"max-width:1%;width:1%;min-width:1%;vertical-align:bottom;","val":[{"type":"text","content":" ","length":6,"tagName":"p","attribs":{}}]},{"style":"max-width:1%;width:1%;min-width:1%;border-top:solid black 1pt;border-bottom:solid black 1pt;padding-right:0;text-align:right;vertical-align:middle;vertical-align:bottom;","val":[{"type":"text","content":" ","length":6,"tagName":"p","attribs":{}}]},{"style":"max-width:12%;width:12%;min-width:12%;border-top:solid black 1pt;border-bottom:solid black 1pt;padding-left:0;padding-right:0;vertical-align:bottom;text-align:center;vertical-align:middle;","val":[{"type":"text","content":"2025","length":4,"tagName":"p","attribs":{}}]},{"style":"max-width:1%;width:1%;min-width:1%;border-top:solid black 1pt;border-bottom:solid black 1pt;padding-left:0;vertical-align:bottom;text-align:center;vertical-align:middle;","val":[{"type":"text","content":" ","length":6,"tagName":"p","attribs":{}}...